Physician profile
Robert B Wilson
NPI 1962473496
$37,303.28
in general payments reported to CMS, 2019-2025
16 companies · $650 in 2025
The $650 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,867 · 2020: $4,472 · 2021: $23K · 2022: $2,012 · 2023: $2,250 · 2024: $1,464 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,064 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $850 · Consulting Fee: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,063.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $850.00 |
| Consulting Fee | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $36,539.31 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Spr Therapeutics, INC | $273.37 | 2019-2023 | Sprint Pns System |
| Scilex Pharmaceuticals INC. | $120.93 | 2019-2023 | Ztlido |
| Vertiflex, INC. | $81.21 | 2019 | |
| Grt US Holding, INC. | $57.51 | 2022 | |
| Arbor Pharmaceuticals, INC. | $37.22 | 2019 | |
| Biodelivery Sciences International, INC. | $35.66 | 2019 | |
| Collegium Pharmaceutical, INC. | $31.83 | 2019 | |
| Relievant Medsystems, INC. | $27.46 | 2019 | |
| Assertio Therapeutics, INC. | $17.55 | 2019 | |
| Medtronic, INC. | $17.12 | 2023 | Intellis Adaptivestim |
| Nalu Medical, INC. | $16.52 | 2022 | |
| Vertical Pharmaceuticals, LLC | $13.28 | 2019 | |
| Horizon Therapeutics Plc | $11.58 | 2021 | |
| Pfizer INC. | $11.39 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.